Successful implantation of cardiovascular-defibrillator systems in patients with elevated defibrillation thresholds  by Brooks, Ross et al.
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Table 1. Clinical Features of the 16 Study Patients
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Amio - amiodarone; CABG
-
coronary artery bypass grafting ; CAD = coronary artery disease ; DCM = dilated cardiomyopathy ; EBS - Ebstein's anomaly ;
F - female
: LVA
-
left ventricular aneurysmectomy ; LVEF = left ventricular ejection fraction ; M = male; Mex = ntexilctine
; MI = myocardial infarction ;
MVR - mitral valve replacement; Proc = procalnamide
; Pt = patient; RHD
= rheumatic heart disease; VF = ventricular fibrillation; VT = ventricular
tachycardia .
shown in Table 1 . Fourteen patients had underlying coro-
nary artery disease, prior myocardial infarction and ad-
vanced left ventricular dysfunction. Two patients had nonisch-
emic dilated cardiomyopathy . The mean left ventricular
ejection fraction for the group was 26 ± 10% . Five patients
had previously undergone coronary artery bypass grafting
(with combined left ventricular aneurysmectomy in one),
and two patients had prior mitral valve replacement (Table
1). Seven patients (44%) were receiving long-term amio-
darone therapy (mean duration 3 ± 4 years, range 0 .4 to 11) .
Five patients were referred from outside hospitals after
attempts to implant a cardioverter-defibrillator device were
unsuccessful owing to high defibrillation thresholds . Four
patients were unexpectedly found to have a high defibrilla-
tion threshold at the time of elective pulse generator replace-
ment. The remaining seven patients had an elevated defibril-
lation threshold at the time of initial cardioverter-
defibrillator implantation at our institution .
Surgical procedures . All patients underwent implantation
and testing under general anesthesia
. Thirteen of 16 patients
had previously undergone one or more cardiac surgical
procedures performed through median sternotomy (3 pa-
tients), left thoracotomy (8 patients), combined median
sternotomy and left thoracotomy (I patient) and combined
median stemotomylsubr iphoid incisions (I patient) (Table
2). The original two• electrode configuration that resulted in
unacceptable defibrillation thresholds consisted of two large
epicardial patches (13 patients), one large and one small
epicardial patch (2 patients) and one small epicardial patch in
conjunction with a superior vena cava coil (I patient) . The
choice of a third 'lectrode was individualized and based on
several considerations including the nature of prior and
current surgical procedures, the preexisting electrode con-
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figuration, as well as logistic and clinical factors (Table 2).
Patients were positioned supine with broad access to the
entire anterior chest within the surgical field .
Intraoperatlve defibrillation threshold testing . Ventricular
fibrillation was induced by rapid ventricular stimulation or
by brief application of alternating current . A period of 10 s
elapsed before defibrllation was attempted . Defibrillation
threshold testing was performed by using an external cardio-
verter device delivering monophasic pulses . The initial
shock energy used was 15 to 20 J . The defibrillation thresh-
old was defined as the lowest energy level used to terminate
ventricular fibrillation on three successive occasions . Un-
successful initial shocks were followed by 35- to 40-J "rescue
shocks" delivered by way of the 1+- ad system, followed by
internal rescue shocks or transt horacic defibrillation if
needed. Initial shocks were unsucce=ssful in all patients, and
defibrillation testing was repeated at higher energy levels in
stepwise increments of 5 J . Twenty-five joules was consid-
ered the maximal allowable defibrillation threshold. Five
minutes was allowed between each ventricular fibrillation
induction. After multiple attempts to achieve satisfactory
defibrillation thresholds <_25 J with a two-electrode system,
the third electrode was incorporated and tested . All patients
eventually required a three-electrode configuration to
achieve a satisfactory defibrillation threshold . In 12 patients,
a "Y" connector (CPI model 6836) was used to connect two
electrodes to form a common electrode pair. In four addi-
tional patients, a common anode was formed by direct
connection with the header of the Medtronic PCD 72I7B
cardioverter-defibrillator device.
Statistical analysis. Data are shown as mean value ± SD .
Paired data were analyzed using the Student
t test. A p
value < 0 .05 was conskdered statistically significant .
Pt
No .
Age (yr)1
Gender
Heart
Disease
Prior
MI
Prior
Surgery
LVEF
(TO)
Arrhythmia
Antiarrhythmic
DrugsClinical Induced
I 53/M CADIRHD Yes
MVR 19 VF VF Amio
2 481M
CAD Yes - 20 VT VF None
3 4741 CAD
Yes - 21 VF VT Mex
4
571M CAD Yes -
25 VF VT
Amio
5 65/M CAD Yes
CABG/LVA 11 VT VT Amio/Mex
S 59/M CAD
Yes CABG 25 VF VT Amio
7 65/M
CAD/EBS Yes - 22 VF VF Amio
8 521M
CAD Yes - 10 VT V7' Amio
9
731M CAD Yes CABG 46 VT VT None
10
61i/M CAD Yes CABG
37 VT VT
Amio
11 661M CAD
Yes 27 VT VT Proc
12 721M
CAD Yes - 39 VT VF Sotalol
13 67M CAD
Yes CABG 2. 1 VT VT
Proc/Mex
14 651F DCM
No 25 VF Nine
I5
801M CAD Yes 28 VT VT L.'sopyramide
16 67/F DCM No MYR 30 VF VT None
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Table 2 . Surgical Approach, Lead Configurations And Results of Intraoperative Defibrillation Threshold T:sting
Config
	
configuration ; DFr = defibrillation threshold ; El . = electrode ; ICD = implanted cardioverter .defibrillator; LT = left thoracotomy ; L":' = left
ventricle ; LV, = left ventricular (inferior wall) ; LV L = left ventricular (large
patch) ; LV, = left ventricular (small p ..tch)
; MED = Medtronic ; MS = median
sternotomy ; Pt = patient ; RA = right atrium
; RV = right ventricle ; RVA = right ventricular apical coiled-spring electrode ; RVL
= right vemricular (large patch) ;
RV, = right ventricular (small patch) ; SVC = superior vena cava coil electrode : SQ = subcutaneous : SX = subxiphoid .
Results
Defibrillation thresholds. The initial defibrillation thresh-
old was >25 J in all 16 patients using the original two-
electrode configuration (Table 2) . With the final three-
electrode configuration, the mean defibrillation threshold
was 19.5 ± 3 .7 J (p < 0 .0001) (Table 2). A mean of 6 ± 3
(range 2 to 12) configurations/patient was tested before the
final configuration was selected . The mean impedance of the
final electrode configuration was 32 ± 6 a.
Electrode configurations and implanted devices (blig . 1,
Table 2). A total of nine different final configurations were
used in the 16 patients. In 10 patients, a common cathode
was formed between two electrodes ; in the other 6 patients,
a common anode was used . The third electrode consisted of
a superior vena cava coil electrode (8 patients), an epicardial
patch (6 patients), a right ventricular coil electrode (I pa-
tient) and an extrathoracic subcutaneous patch (I patient) . In
;0 patients with a defibrillation threshold of 20 to 25 J, a high
output (34 to 35 J) pulse generator was implanted (CPI 1555
in 4 patients, Medtronic PCD 7217B in 4 and CPI PRX 1705
in 2). Six patients with inal defibrillation thresholds -<20 J
received a standard 30-J output device (CPI Ventak 1550 in
three and CPI Ventak 1600 in three) . All cardioverter-
defibrillator devices delivered monophasic pulse waveforms.
Postoperative electrophysiologic testing and follow-up .
Fifteen patients recovered uneventually from the opera-
tion and were discharged 8 ± 3 days (mean ± SD) after
cardioverter-defibrillator implantation . A 16th patient died in
the hospital 3 days postoperatively from sepsis and cardio-
genic shock in the setting of end-stage left ventricular
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dysfunction . Predischarge electrophysiologic testing was
performed in 14 of 15 patients . In ail patients, electrically
induced ventricular fibrillation was terminated by the first
shock at the programmed maximal energy level of the
cardioverter-defibrillator device . All patients discharged
from the hospital are alive a mean of 9 ± 5 months after
discharge . During the follow-up period, 4 patients (25%)
have received one or more appropriate cardioverter-
defibrillator discharges . Two additional patients with anti-
tachycardia pacing devices have received successful
antitachycardia pacing therapy for monomorphic ventricular
tachycardia,
Discussion
Elevated defibrillation threshold is an important, although
fortunately uncommon, clinical problem confronting physi-
cians implanting cardioverter-defibrillator systems . The in-
cidence of high defibrillation thresholds is unknown and
seems to depend on the criteria used to define this problem .
Previous data from individual series suggested an incidence
between 5% (7) and 18% (8) . In a recent multicenter study,
Epstein et al. (6) cited 4.6% incidence using >25 J as the
cutoff. Our definition (>25 J) is similar and is based on a
practical endpoint-a minimal "safety margin" of 10 J
between the intraoperative defibrillation threshold and the
maximal stored energy of currently available devices . 01'
the 16 patients described, we used a third electrode to lower
the defibrillation threshold and create an adequate safety
margin for cardioverter-defibrillator implantation
. Several
Pt
No .
Previous
Approach
Original Config
Initial
DFT
(J)
Current
Approach
Position
of 3rd
EL
Config
Tested
(no.)
Final Config Final
DFt'
(J)
Final
Impedance
(11) lCD Device
Cathode Anode
Cathode Anode
I MS/LT LVL RVL >25 SVC 10 LV/RV SVC s25 27 CPI 1555
2 LT LV,, RV, >25 - SVC 3 LV/!RV SVC 5520 31 CPI 1550
3 - LVL RVL >25 Subcostal LV, 6 LV,/LV RV 5_25 27 CPI 1555
4 LT LV, RVL >25 Subxiphoid LV, 6 LV,IRV LV =_20 29
CPI 1555
5 MS LVL RVL >25 Left and right
thoracotomy
LV, 2 LV RV/LV X18 40 MED 7217B
6 MS LV, RV,, >25 SVC 3 LV/RV SVC
:s 15 27
CPI 1550
7 LT LVL RVL >40 SVC 5 SVC RV/LV 5_24 27 MED 72178
8 LT LVL RVs >30 - SVC 3 LV/RV SVC =_20 27 CPI 1550
9 LT LVL RV, >25 Subxiphoid LV, 10 LV, RV/LV 5_20 30 CPI 1550
10 LT LV, SVC >25 Suhcostal SQ 4 SQ/SVC LV X24 43 CPI 1705
II LT LVL RV,_ >25 - SVC 5 LV/RV SVC s15 39 CPI 1600
12 LVL RV,, >24 Left thoracotomy RVA 12 LV RV/RVA s18 31 MED72170
13 MS LVL RV, . >24 Left thoracotomy SVC I I RV SVC/LV s l8 45 MED 7217B
14 -- LVL RV L. >25 Subxiphoid RA 4 LV/RV RA -15 28 CPI 1600
15 LT LVL RVL >34 - SVC 4 RV SVC/LV s20 31 CPI 1705
16 SX LVL RVL >40 Median sternotomy RA 2 LV/ttV RA s15 32 CPI 1600
572
	
BROOKS ET AL .
HIGH DEFIBRILLATION THRESHOLDS
J
Figure 1 . The various electrode configurations used in the 16 study
patients as reconstructed from chest roentgenograms . 1--1 denotes
the electrode or electrodes used as the cathode ; (+] denotes those
used as the anode. The arrows show the direction or current now
during defibrillation from anode to cathode . The numbers corre-
spond to the patients listed in Tables l and 2 . The most common
confutation used (superior vena cave or right atrial patch as single
anode versus combined left and right ventricular patches av cathode)
are depicted in panels l, 2, 3, 6, 8, 11, 14 and 16 .
different electrode configurations proved successful (Fig . I) .
The configurations selected for testing were individualized
on the basis of prior and current surgical considerations,
preexisting electrode configuration, individual anatomy, the
desire to avuid another thoracotomy and other factors. The
most common configuration used incorporated a superior
versa cava coil (n = 5) or right atrial patch (n = 3) electrode
as single anode, in conjunction with right and left ventricular
patch electrodes joined to form a common cathode (Fig . 1 .
Table 2),
ExpeieRce with a three-electrode system. Few clinical
data exist on the use of a three-electrode system . Earlier
work in animals (9) showed that three epicardial patch
electrodes generally resulted in lower defibrillation thresh-
olds than a two-patch lead system does (9). A recent clinical
report showed that defibrillation thresholds were lower with
three, as compared with two epicardial patches; but this
study was not performed in patients with a high defibrillation
JACC Vol . 22, No. 2
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threshold (10). Our study extends these findings and demon-
strates the effectiveness of a three-electrode system in
lowering elevated defibrillation thresholds . Because success-
ful defibrillation is dependent on depolarization of a critical
mass of myocardium (11), a simple explanation for the
superiority of the three-electrode system is that a greater
total mass of myocardium is defibrillated with three than
with two electrodes. The use of three electrodes also permits
bidirectional current delivery (Fig . 1). Spatial separation of
the defibrillating pulses may result in more uniform current
density, more widespread current distribution and increased
defibrillation efficacy . In addition, with most configurations
used, the current pathways were divergent because the
common anode or cathode incorporated electrodes on oppo-
site ventricles and opposite sides of the heart, or both (Table
2). This arrangement might facilitate more effective current
delivery, particularly across the interventricular septum.
Adequate transseptal depolarization has been cited as a
factor critical to successful defibrillation (12). Some data also
suggest improved defibrillation efficacy with bidirectional
shocks delivered through sequential as compared to simul-
taneous current pathways (12) . Temporal in addition to
spatial separation of pulses may further improve defibrilla-
!ion efficacy, as was the case in one patient in our study .
Limitations of the study. The present study was not
prospective in design, and the various electrode configura-
tions were not randomly tested. Because of patient differ-
ences, prolonged anesthesia times, protracted intraoperative
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testing and the concern over delivery of multiple shocks to
hearts with advanced disease, not all configurations were
tested in each patient and the relative effectiveness of the
individual configurations could not be directly compared .
Once a satisfactory electrode configuration was found, we
elected not to conduct trials of other electrode configurations
to minimize patient morbidity . Although the success rate
with the three-electrode system was 100% in our patients,
the study group was relatively small (95% Cl
W
0% to 21%) .
The upper confidence limit of 21% implies that in a larger
group a failure rate of up to 21% may be expected with a
three-electrode system and our results need to be tempered
accordingly (13) . In addition, all implanted pulse generators
delivered monophasic pulse waveforms . Biphasic shocks
were not compared with monophasic pulses, and whether
biphasic shocks would have resulted in satisfactory defibril-
lation thresholds with the initial two-electrode configuration
is not known.
Causes of high defibrillation energy requirements . Factors
related to or implicated as a cause of high defibrillation
thresholds include underlying cardiac disease (8,12); heart
mass (12) ; drug therapy (8,14-18) ; the size, position, config-
uration and number of defibrillating leads (19,20) ; the shock
waveform (9,12,18,21,22) and the direction of the delivered
shock (5). Our patient group was fairly homogeneous in that
14 of the 16 patients had coronary artery disease, prior
myocardial infarction and left ventricular dysfunction . Two
additional patients had nonischemic dilated cardiomyopathy
with reduced left ventricular function . The spectrum of
cardiac diseases in our patients is similar to that described in
other studies and, in itself, does not explain the high defi-
brillation thresholds we observed . Seven of the 16 patients
(44%) received long-term amiodarone therapy (mean dura-
tion 3 ± 4 years), which has previously been shown to
increase the energy requirements for defibrillation
(15,16,18). One option in these patients is to withdraw
amiodarone therapy and to repeat defibrillation threshold
testing 6 to 10 weeks later (18) . This approach is not possible
in patients who require continuation of amiodarone therapy,
as was the case in six of our patients, and may be unaccept-
able in other patients because of prolonged hospital stay and
costs involved . In some patients, optimal positioning of the
patch electrodes may be difficult to achieve because of
inadequate surgical exposure or extensive mediastinal fibro-
sis resulting from earlier cardiac surgery . With severe car-
diac disease and poor left ventricular function, amiodarone
exposure, suboptimal patch positioning in addition to other
unknown factors may act synergistically to increase the en-,rgy
required for successful defibrillation in these patients .
Clinical implications . The present study demonstrates
the effectiveness of a third electrode in lowering the defib-
rillation threshold in patients with an initial high defibril-
lation threshold . This strategy resulted in an acceptable
safety margin and permitted implantation of a cardioverter-
defibrillator in these patients . Moreover, short-term
follow-up has shown effective use of the implanted system in
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a number of patients . Failure to achieve an adequate defi-
brillation threshold and to create an acceptable safety margin
is associated with a high rate of sudden cardiac death,
presumably from failure to defibrillate recurrent spontane-
ous ventricular arrhythmias (6) . Our report comprises a
consecutive series of patients with a high defibrillation
threshold and suggests that in most patients the problem can
be managed successfully if enough combinations are tested
after a third electrode is incorporated . When a third elec-
trode becomes necessary, a superior vena cava coil elec-
trode should be initially considered and is our preferred
approach whenever high defibrillation thresholds are antici-
pated. A superior vena cava coil electrode (or right atrial
patch) may be useful when the right ventricular patch is
positioned to the left of the midline (for example, panels 1, 6,
7, 8,11, 13, and f 5, Fig . 1). A diaphragmatic patch may work
well in conjunction with two-patch electrodes placed over
the lateral aspects of the heart (panels 3, 4, 9 and 16, Fig . 1) .
Testing should begin with the superior vena cava coil or right
atrial patch serving as a single anode, with the other patches
combined as the cathode . Reversing the polarity can be tried
next if this configuration is unsatisfactory . Ultimately, some
trial and error of additional configurations may be necessary
to define a satisfactory configuration in individual patients .
The benefit of successful implantation of a cardioverter-
defibrillator in patients with a high defibrillation threshold
must be weighed against potential risks associated with the
protracted intraoperative testing necessary to achieve this
end point in some cases . One patient in our series died after
cardioverter-defibrillator implantation . This patient had ad-
vanced left ventricular dysfunction and congestive heart
failure, and one cannot exclude the pr,ssibility that a pro-
longed anesthetic time and the delivery of multiple shocks
during interoperative testing contributed to his death . In the
future, high defibrillation thresholds may be less problematic
to manage when fourth-generation cardioverter-defibrillator
devices with a higher maximal energy output become avail-
able from a variety of manufacturers. Newer devices may
also permit delivery of biphasic (23) or sequential shock
waveforms (12), which may result in lower defibrillation
thresholds relative to monophasic or simultaneous pulses.
These features will be expected to streamline intraoperative
testing and further reduce morbidity associated with implan-
tation of these systems . Despite these advances, there may
still be patients with an elevated defibrillation threshold who
will require three or more electrodes to permit implantation
of a cardioverter-defibrillator .
Conclusions . In summary, patients with a high initial
defibrillation threshold can generally undergo successful
cardiover'er-defibrillator implantation when a third elec-
trode is used to form a three-electrode system and create
bidirectional current pathways
. In all patients included in
this study, defibrillation thresholds were sufficiently lowered
to provide an acceptable safety margin for normal device
function
. An individualized approach is necessary to mini-
mize the extent of surgery necessary to implant additional
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defibrillating patch electrodes, particularly in patients with
electrodes placed at the time of previous sternotomy or
thoracotomy. When a third electrode is required, a superior
vena cava coil electrode may obviate the need for a third
epicardial patch electrode in most patients . Newer trans-
venous electrode systems, which incorporate multiple intra-
vascular electrodes, my further facilitate the managemeit
of patients with a high defibrillation threshold .
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